Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,872.00    -8.00 (-0.43%)
Bid:
1,864.00
Ask:
1,867.00
Spread: 3.00 (0.161%)
Market Cap: £3.67b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Director/PDMR Shareholding

5 Apr 2018 16:22

RNS Number : 0199K
Softcat PLC
05 April 2018
 

Softcat plc (the "Company")

 

Notification of Transactions by

Persons Discharging Managerial Responsibilities

 

 

The following notification relates to the award of nil-cost options to person discharging managerial responsibilities ("PDMR") on 4 April 2018 under the Softcat plc Long Term Incentive Plan ("LTIP").  

 

Softcat plc Long Term Incentive Plan

 

On 4 April 2018, an award of nil-cost options to acquire 66,864 shares was made to Graeme Watt, a director and PDMR. The number of shares over which the nil-cost option was awarded has been calculated by reference to the closing middle market quotation of the ordinary shares derived from the Daily Official List on the dealing day preceding the date of grant (6.73 pence). The award will vest subject to the performance conditions outlined below.

 

 

Performance Conditions and Vesting of Awards

 

These nil-cost options are subject to the rules of the LTIP and will vest depending on performance against Total Shareholder Return ("TSR") and Earnings per Share ("EPS") targets as measured over a three year performance period.

 

50% of the Award will be subject to the Company's relative TSR performance against the FTSE 250 (excluding real estate and investment trusts):

 

TSR performance % of Award vesting

Below median Nil

At median 30%

Upper quartile or above 100%

 

50% of the Award will be subject to the Company's EPS for FY 2020:

 

EPS Growth % of Award vesting

Less than 23.7 pence Nil

23.7 pence 20%

26.9 pence or above 100%

 

There will be straight line vesting between the points as outlined above.

 

The normal date of vesting for the nil-cost options outlined above will be 4 April 2021 and the last date for exercise will be 3 April 2028, with dividend equivalents payable in respect of the vesting of nil-cost options in accordance with the rules of the LTIP.

 

For further information on the LTIP, please refer to the Company's Annual Report and Accounts.

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Graeme Watt

 

2.

Reason for the notification

a)

Position / status

Chief Executive

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Softcat plc

b)

LEI

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares of £0.0005 each

 

 

ISIN: GB00BYZDVK82

b)

Nature of the transaction

Grant of nil cost option over Ordinary Shares of £0.0005 each under the Softcat plc Long Term Incentive Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.00

66,864

d)

Aggregated information

Aggregated volume

Price

 

N/A

e)

Date of the transaction

 

2018-04-04

f)

Place of the transaction

 

Outside a trading venue

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHZMGGDKKGGRZM
Date   Source Headline
9th Feb 20183:28 pmRNSDirector/PDMR Shareholding
6th Feb 20187:00 amRNSPre Interim Results Trading Update
10th Jan 20182:12 pmRNSDirector/PDMR Shareholding
2nd Jan 20184:39 pmRNSDirector/PDMR Shareholding
12th Dec 20175:47 pmRNSHolding(s) in Company
12th Dec 20175:34 pmRNSHolding(s) in Company
11th Dec 201711:22 amRNSDirector/PDMR Shareholding
8th Dec 20174:21 pmRNSTotal Voting Rights
8th Dec 20174:21 pmRNSResult of AGM
30th Nov 20175:26 pmRNSDirector/PDMR Shareholding
30th Nov 20175:25 pmRNSDirector/PDMR Shareholding
29th Nov 20177:00 amRNSQ1 2018 Trading Update
16th Nov 20174:24 pmRNSReplacement - Director/PDMR Shareholding
16th Nov 20174:08 pmRNSDirector/PDMR Shareholding
15th Nov 20179:36 amRNSHolding(s) in Company
13th Nov 20177:00 amRNSGraeme Watt to be appointed as new CEO
9th Nov 20173:01 pmRNSDirector/PDMR Shareholding
3rd Nov 201712:09 pmRNSAnnual Financial Report
31st Oct 20177:00 amRNSAdditional Listing
18th Oct 20177:00 amRNSFinal Results
10th Oct 20173:04 pmRNSDirector/PDMR Shareholding
4th Oct 20174:33 pmRNSHolding(s) in Company
18th Sep 20179:00 amRNSNotice of Results
12th Sep 20172:23 pmRNSDirector/PDMR Shareholding
10th Aug 20174:24 pmRNSDirector/PDMR Shareholding
25th Jul 20173:23 pmRNSDirector/PDMR Shareholding
11th Jul 20174:31 pmRNSDirector/PDMR Shareholding
9th Jun 201711:08 amRNSDirector/PDMR Shareholding
26th May 20172:31 pmRNSHolding(s) in Company
24th May 20177:00 amRNSBoard Changes
24th May 20177:00 amRNSQ3 2017 Trading Update
11th May 20171:15 pmRNSDirector/PDMR Shareholding
8th May 20174:46 pmRNSHolding(s) in Company
28th Apr 201711:40 amRNSDirector/PDMR Shareholding
11th Apr 20174:30 pmRNSDirector/PDMR Shareholding
22nd Mar 20177:00 amRNSHalf-year Report
9th Mar 20172:45 pmRNSDirector/PDMR Shareholding
20th Feb 201710:00 amRNSNotice of Results
10th Feb 20179:57 amRNSDirector/PDMR Shareholding
12th Jan 20173:08 pmRNSDirector/PDMR Shareholding
4th Jan 20174:55 pmRNSDirectorate Change
13th Dec 201610:26 amRNSDirector/PDMR Shareholding
8th Dec 20165:42 pmRNSResult of AGM
8th Dec 20165:35 pmRNSDirector/PDMR Shareholding
23rd Nov 20167:00 amRNSQ1 2017 Trading Update
16th Nov 20165:52 pmRNSDirector/PDMR Shareholding
10th Nov 20169:21 amRNSDirector/PDMR Shareholding
9th Nov 20167:00 amRNSTotal Voting Rights
7th Nov 20167:00 amRNSAdditional Listing of Shares
2nd Nov 20162:58 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.